Loading...

SciBase Holding

OM:SCIB
Snowflake Description

Flawless balance sheet with limited growth.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
SCIB
OM
SEK73M
Market Cap
  1. Home
  2. SE
  3. Healthcare
Company description

SciBase Holding AB (publ), a medical technology company, develops and sells skin cancer diagnostic instruments in Europe and internationally. The last earnings update was 9 days ago. More info.


Add to Portfolio Compare Print
  • SciBase Holding has significant price volatility in the past 3 months.
SCIB Share Price and Events
7 Day Returns
7.8%
OM:SCIB
1%
SE Medical Equipment
0.8%
SE Market
1 Year Returns
-40.1%
OM:SCIB
26.9%
SE Medical Equipment
-0.6%
SE Market
SCIB Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
SciBase Holding (SCIB) 7.8% 4.3% 15.2% -40.1% -80.7% -
SE Medical Equipment 1% 6% 6% 26.9% 34.2% 8.9%
SE Market 0.8% -2.3% 2.4% -0.6% 14.3% 18.2%
1 Year Return vs Industry and Market
  • SCIB underperformed the Medical Equipment industry which returned 26.9% over the past year.
  • SCIB underperformed the Market in Sweden which returned -0.6% over the past year.
Price Volatility
SCIB
Industry
5yr Volatility vs Market

SCIB Value

 Is SciBase Holding undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for SciBase Holding. This is due to cash flow or dividend data being unavailable. The share price is SEK4.4.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for SciBase Holding's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are SciBase Holding's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OM:SCIB PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in SEK SEK-2.62
OM:SCIB Share Price ** OM (2019-05-17) in SEK SEK4.4
Sweden Medical Equipment Industry PE Ratio Median Figure of 12 Publicly-Listed Medical Equipment Companies 37.74x
Sweden Market PE Ratio Median Figure of 323 Publicly-Listed Companies 16.89x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of SciBase Holding.

OM:SCIB PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= OM:SCIB Share Price ÷ EPS (both in SEK)

= 4.4 ÷ -2.62

-1.68x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • SciBase Holding is loss making, we can't compare its value to the SE Medical Equipment industry average.
  • SciBase Holding is loss making, we can't compare the value of its earnings to the Sweden market.
Price based on expected Growth
Does SciBase Holding's expected growth come at a high price?
Raw Data
OM:SCIB PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -1.68x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts
18%per year
Sweden Medical Equipment Industry PEG Ratio Median Figure of 8 Publicly-Listed Medical Equipment Companies 1.68x
Sweden Market PEG Ratio Median Figure of 235 Publicly-Listed Companies 1.36x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for SciBase Holding, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on SciBase Holding's assets?
Raw Data
OM:SCIB PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in SEK SEK3.78
OM:SCIB Share Price * OM (2019-05-17) in SEK SEK4.4
Sweden Medical Equipment Industry PB Ratio Median Figure of 42 Publicly-Listed Medical Equipment Companies 4.44x
Sweden Market PB Ratio Median Figure of 567 Publicly-Listed Companies 2.46x
OM:SCIB PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= OM:SCIB Share Price ÷ Book Value per Share (both in SEK)

= 4.4 ÷ 3.78

1.16x

* Primary Listing of SciBase Holding.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • SciBase Holding is good value based on assets compared to the SE Medical Equipment industry average.
X
Value checks
We assess SciBase Holding's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. SciBase Holding has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

SCIB Future Performance

 How is SciBase Holding expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
18%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is SciBase Holding expected to grow at an attractive rate?
  • Unable to compare SciBase Holding's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.
Growth vs Market Checks
  • Unable to compare SciBase Holding's earnings growth to the Sweden market average as it is expected to be loss making during the next 1-3 years.
  • SciBase Holding's revenue growth is expected to exceed the Sweden market average.
Annual Growth Rates Comparison
Raw Data
OM:SCIB Future Growth Rates Data Sources
Data Point Source Value (per year)
OM:SCIB Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts 18%
OM:SCIB Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 2 Analysts 50%
Sweden Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 28.5%
Sweden Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 13.3%
Sweden Market Earnings Growth Rate Market Cap Weighted Average 8.6%
Sweden Market Revenue Growth Rate Market Cap Weighted Average 4.6%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OM:SCIB Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
All numbers in SEK Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OM:SCIB Future Estimates Data
Date (Data in SEK Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-12-31 63 1
2021-12-31 38 -26 -26 2
2020-12-31 24 -35 -33 2
2019-12-31 11 -40 -37 1
OM:SCIB Past Financials Data
Date (Data in SEK Millions) Revenue Cash Flow Net Income *
2019-03-31 7 -37 -43
2018-12-31 7 -37 -44
2018-09-30 7 -39 -43
2018-06-30 7 -41 -39
2018-03-31 7 -42 -41
2017-12-31 7 -44 -42
2017-09-30 7 -46 -47
2017-06-30 7 -47 -50
2017-03-31 7 -49 -53
2016-12-31 6 -48 -53
2016-09-30 6 -49 -50
2016-06-30 5 -48 -47

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • SciBase Holding is not considered high growth as it is expected to be loss making for the next 1-3 years.
  • SciBase Holding's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OM:SCIB Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below

All data from SciBase Holding Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OM:SCIB Future Estimates Data
Date (Data in SEK Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-12-31 -0.90 -0.90 -0.90 1.00
2021-12-31 -1.57 -1.44 -1.70 2.00
2020-12-31 -1.94 -1.78 -2.10 2.00
2019-12-31 -2.25 -2.25 -2.25 1.00
OM:SCIB Past Financials Data
Date (Data in SEK Millions) EPS *
2019-03-31 -2.62
2018-12-31 -2.66
2018-09-30 -2.92
2018-06-30 -3.09
2018-03-31 -3.83
2017-12-31 -5.00
2017-09-30 -5.65
2017-06-30 -6.08
2017-03-31 -6.41
2016-12-31 -6.41
2016-09-30 -5.99
2016-06-30 -5.73

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if SciBase Holding will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess SciBase Holding's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Sweden market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Sweden market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
SciBase Holding has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

SCIB Past Performance

  How has SciBase Holding performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare SciBase Holding's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • SciBase Holding does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare SciBase Holding's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare SciBase Holding's 1-year growth to the SE Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
SciBase Holding's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from SciBase Holding Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OM:SCIB Past Revenue, Cash Flow and Net Income Data
Date (Data in SEK Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 7.33 -43.47 32.18 10.59
2018-12-31 6.90 -44.22 32.85 10.40
2018-09-30 6.76 -43.01 32.15 9.91
2018-06-30 6.57 -39.06 31.91 10.09
2018-03-31 7.04 -40.51 32.04 11.17
2017-12-31 6.86 -42.46 31.92 12.86
2017-09-30 6.91 -46.79 32.50 14.93
2017-06-30 7.32 -50.38 33.55 17.48
2017-03-31 7.13 -53.10 34.41 19.17
2016-12-31 6.44 -53.09 34.73 18.65
2016-09-30 5.68 -49.62 34.26 16.96
2016-06-30 5.10 -47.48 33.86 14.80
2016-03-31 4.16 -43.95 32.90 11.85
2015-12-31 4.15 -41.53 31.57 10.56
2015-09-30 3.43 -40.63 30.70 10.35
2015-06-30 3.25 -38.31 29.00 9.19
2015-03-31 2.59 -38.92 29.67 9.12
2014-12-31 1.60 -38.76 29.60 8.97
2013-12-31 0.10 -79.50 24.17 10.61
2012-12-31 -40.96 18.22 15.35

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if SciBase Holding has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if SciBase Holding has efficiently used its assets last year compared to the SE Medical Equipment industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if SciBase Holding improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess SciBase Holding's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
SciBase Holding has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

SCIB Health

 How is SciBase Holding's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up SciBase Holding's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • SciBase Holding is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • SciBase Holding's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of SciBase Holding's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • SciBase Holding has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from SciBase Holding Company Filings, last reported 1 month ago.

OM:SCIB Past Debt and Equity Data
Date (Data in SEK Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 62.78 0.00 58.06
2018-12-31 71.48 0.00 67.51
2018-09-30 82.52 0.00 77.55
2018-06-30 95.69 0.00 85.23
2018-03-31 105.97 0.00 95.54
2017-12-31 115.72 0.00 110.02
2017-09-30 60.56 0.00 50.95
2017-06-30 69.40 0.00 60.97
2017-03-31 81.09 0.00 72.63
2016-12-31 92.71 0.00 84.96
2016-09-30 107.38 0.00 98.27
2016-06-30 119.72 0.00 108.79
2016-03-31 134.15 0.00 122.24
2015-12-31 145.71 0.00 133.74
2015-09-30 156.86 0.00 147.66
2015-06-30 166.79 0.00 165.60
2015-03-31 23.47 0.00 17.31
2014-12-31 32.65 0.00 27.57
2013-12-31 36.18 0.26 31.86
2012-12-31 -23.69 0.00 18.78
  • SciBase Holding has no debt.
  • SciBase Holding has no debt compared to 5 years ago when it was 0.5%.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • SciBase Holding has sufficient cash runway for 1.6 years based on current free cash flow.
  • SciBase Holding has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of -10.2% each year.
X
Financial health checks
We assess SciBase Holding's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. SciBase Holding has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

SCIB Dividends

 What is SciBase Holding's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from SciBase Holding dividends. Estimated to be 0% next year.
If you bought SEK2,000 of SciBase Holding shares you are expected to receive SEK0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate SciBase Holding's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate SciBase Holding's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OM:SCIB Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
Sweden Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 8 Stocks 1.1%
Sweden Market Average Dividend Yield Market Cap Weighted Average of 243 Stocks 3.2%
Sweden Minimum Threshold Dividend Yield 10th Percentile 1.1%
Sweden Bottom 25% Dividend Yield 25th Percentile 1.8%
Sweden Top 25% Dividend Yield 75th Percentile 4.4%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

OM:SCIB Future Dividends Estimate Data
Date (Data in SEK) Dividend per Share (annual) Avg. No. Analysts
2022-12-31
2021-12-31 0.00 1.00
2020-12-31 0.00 1.00
2019-12-31 0.00 1.00

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as SciBase Holding has not reported any payouts.
  • Unable to verify if SciBase Holding's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of SciBase Holding's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as SciBase Holding has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of SciBase Holding's dividends in 3 years as they are not expected to pay a notable one for Sweden.
X
Income/ dividend checks
We assess SciBase Holding's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can SciBase Holding afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. SciBase Holding has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

SCIB Management

 What is the CEO of SciBase Holding's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Simon Grant
COMPENSATION SEK2,231,000
AGE 51
TENURE AS CEO 5.3 years
CEO Bio

Mr. Simon Grant serves as the Chief Executive Officer of SciBase Holding AB and has been its President since 2014. Mr. Grant served as Chief Executive Officer of Neoventa Medical AB. He has extensive experience within the medical device industry, especially with diagnostic devices where he has focused on commercialization of new clinical technologies. He has held senior positions within management and sales and marketing in medtech startups such as Synectics Medical and Neoventa and in established multinationals such as Medtronic. He has always worked with an international focus and has been based in Scandinavia, the US and Asia.

CEO Compensation
  • Simon's compensation has increased whilst company is loss making.
  • Simon's remuneration is higher than average for companies of similar size in Sweden.
Management Team Tenure

Average tenure and age of the SciBase Holding management team in years:

4.8
Average Tenure
53.5
Average Age
  • The tenure for the SciBase Holding management team is about average.
Management Team

Simon Grant

TITLE
CEO & President
COMPENSATION
SEK2M
AGE
51
TENURE
5.3 yrs

Michael Colérus

TITLE
Chief Financial Officer
COMPENSATION
SEK273K
AGE
56
TENURE
5.3 yrs

Per Svedenhag

TITLE
Head of Business Development & Marketing
COMPENSATION
SEK1M
AGE
60
TENURE
4.3 yrs

Tobias Bergenblad

TITLE
Global Sales Director
AGE
45
TENURE
4.3 yrs
Board of Directors Tenure

Average tenure and age of the SciBase Holding board of directors in years:

4.1
Average Tenure
52
Average Age
  • The tenure for the SciBase Holding board of directors is about average.
Board of Directors

Tord Lendau

TITLE
Chairman
COMPENSATION
SEK200K
AGE
61
TENURE
5.3 yrs

Thomas Eklund

TITLE
Director
COMPENSATION
SEK150K
AGE
51
TENURE
2 yrs

Per Aniansson

TITLE
Director
AGE
52
TENURE
5.3 yrs

Allan Halpern

TITLE
Member of Scientific Advisory Board
TENURE
4.1 yrs

David Elder

TITLE
Member of Scientific Advisory Board
TENURE
4.1 yrs

Scott Menzies

TITLE
Member of Scientific Advisory Board
TENURE
4.1 yrs

Josep Malvehy

TITLE
Member of Scientific Advisory Board
TENURE
4.1 yrs

Holger Hänßle

TITLE
Member of Scientific Advisory Board
TENURE
4.1 yrs

Thomas Taapken

TITLE
Director
COMPENSATION
SEK150K
AGE
53
TENURE
2 yrs

Diana Ferro

TITLE
Director
COMPENSATION
SEK150K
AGE
52
TENURE
2 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (SEK) Value (SEK)
07. Jun 18 Buy Tord Lendau Individual 05. Jun 18 05. Jun 18 42,300 SEK7.00 SEK296,100
X
Management checks
We assess SciBase Holding's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. SciBase Holding has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

SCIB News

Simply Wall St News

Should You Take Comfort From Insider Transactions At SciBase Holding AB (publ) (STO:SCIB)?

We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. … So shareholders might well want to know whether insiders have been buying or selling shares in SciBase Holding AB (publ) (STO:SCIB). … But logic dictates you should pay some attention to whether insiders are buying or selling shares.

Simply Wall St -

Does The SciBase Holding AB (publ) (STO:SCIB) Share Price Fall With The Market?

If you're interested in SciBase Holding AB (publ) (STO:SCIB), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio. … Beta is a widely used metric to measure a stock's exposure to market risk (volatility). … A stock with a beta below one is either less volatile than the market, or more volatile but not corellated with the overall market.

Simply Wall St -

Easy Come, Easy Go: How SciBase Holding (STO:SCIB) Shareholders Got Unlucky And Saw 85% Of Their Cash Evaporate

While it may not be enough for some shareholders, we think it is good to see the SciBase Holding AB (publ) (STO:SCIB) share price up 13% in a single quarter. … Investors will be hoping that SciBase Holding can make progress and gain better traction for the business, before it runs low on cash. … SciBase Holding has already given some investors a taste of the bitter losses that high risk investing can cause.

Simply Wall St -

Do Insiders Own Lots Of Shares In SciBase Holding AB (publ) (STO:SCIB)?

Every investor in SciBase Holding AB (publ) (STO:SCIB) should be aware of the most powerful shareholder groups. … SciBase Holding is not a large company by global standards. … See our latest analysis for SciBase Holding

Simply Wall St -

What Do Analysts Think About SciBase Holding AB (publ)'s (STO:SCIB) Earnings Outlook?

Help shape the future of investing tools and receive a $20 prize! … The latest earnings release SciBase Holding AB (publ)'s (STO:SCIB) announced in December 2018 … that losses became smaller relative to the prrior year's level

Simply Wall St -

Is SciBase Holding AB (publ) (STO:SCIB) A Financially Sound Company?

The direct benefit for SciBase Holding AB (publ) (STO:SCIB), which sports a zero-debt capital structure, to include debt in its capital structure is the reduced cost of capital. … Is SCIB right in choosing financial flexibility over lower cost of capital … Debt capital generally has lower cost of capital compared to equity funding.

Simply Wall St -

Could The SciBase Holding AB (publ) (STO:SCIB) Ownership Structure Tell Us Something Useful?

Generally speaking, as a company grows, institutions will increase their ownership. … SciBase Holding is not a large company by global standards. … View our latest analysis for SciBase Holding

Simply Wall St -

Why SciBase Holding AB (publ)'s (STO:SCIB) CEO Salary Matters To You

At the time of writing our data says that SciBase Holding AB (publ) has a market cap of kr60m, and is paying total annual CEO compensation of kr2m. … We looked at a group of companies with market capitalizations under kr1.8b, and the median CEO compensation was kr2m. … As you can see, Simon Grant is paid more than the median CEO pay at companies of a similar size, in the same market

Simply Wall St -

Who Owns Most Of SciBase Holding AB (publ) (STO:SCIB)?

In this article, I will take a quick look at SciBase Holding AB (publ)’s (STO:SCIB) recent ownership structure – an unconventional investing subject, but an important one. … Ownership structure of a company has been found to affect share performance over time. … Therefore, it is beneficial for us to examine SCIB's ownership structure in more detail.

Simply Wall St -

Have Investors Priced In SciBase Holding AB (publ)'s (STO:SCIB) Growth?

SciBase Holding AB (publ) (STO:SCIB), a medical equipment company based in Sweden,. … A question to answer is whether SciBase Holding's current trading price of SEK6.75 reflective of the actual value of the? … Let’s take a look at SciBase Holding’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change

Simply Wall St -

SCIB Company Info

Description

SciBase Holding AB (publ), a medical technology company, develops and sells skin cancer diagnostic instruments in Europe and internationally. The company offers Nevisense, a point-of-care detection device for non-visual detection of malignant melanoma. It serves public hospitals and private dermatology clinics. The company has a collaboration agreement with Swiss Institute of Allergy and Asthma Research. The company was founded in 1998 and is headquartered in Stockholm, Sweden.

Details
Name: SciBase Holding AB (publ)
SCIB
Exchange: OM
Founded: 1998
SEK73,119,644
16,618,101
Website: http://www.scibase.com
Address: SciBase Holding AB (publ)
Landsvägen 39,
Sundbyberg,
Stockholm,
Stockholm County, 172 63,
Sweden
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
OM SCIB Ordinary Shares OMX Nordic Exchange Stockholm SE SEK 02. Jun 2015
Number of employees
Current staff
Staff numbers
21
SciBase Holding employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/19 22:45
End of day share price update: 2019/05/17 00:00
Last estimates confirmation: 2019/05/13
Last earnings filing: 2019/05/10
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.